ATE285765T1 - Kapsel, enthaltend ein dioxabicyclo(3.3.0)oktan - Google Patents

Kapsel, enthaltend ein dioxabicyclo(3.3.0)oktan

Info

Publication number: ATE285765T1
Authority: AT; Austria
Prior art keywords: sup; octane; dioxabicyclo; methoxy; methylenedioxyphenyl
Prior art date: 1989-07-21

Application number

AT97112931T

Other languages

English (en)

Inventor

Yoshifumi Shinmen

Kengo Akimoto

Sumio Asami

Yoshihide Suwa

Yoshinori Kitagawa

Michihiro Sugano

Hideaki Yamada

Sakayu Shimizu

Original Assignee

Suntory Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-07-21

Filing date

1990-07-20

Publication date

2005-01-15

1989-07-21 Priority claimed from JP1187497A external-priority patent/JP3001589B2/ja

1990-07-20 Application filed by Suntory Ltd filed Critical Suntory Ltd

2005-01-15 Application granted granted Critical

2005-01-15 Publication of ATE285765T1 publication Critical patent/ATE285765T1/de

Links

XNWFXTOHNKPYMK-UHFFFAOYSA-N 3,3a,4,5,6,6a-hexahydrocyclopenta[c]dioxole Chemical compound C1OOC2CCCC21 XNWFXTOHNKPYMK-UHFFFAOYSA-N 0.000 title 1
239000002775 capsule Substances 0.000 title 1
PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 abstract 2
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 abstract 2
-1 octane compound Chemical class 0.000 abstract 2
ZZMNWJVJUKMZJY-AFHBHXEDSA-N Sesamolin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3OC2=CC=C3OCOC3=C2)=C1 ZZMNWJVJUKMZJY-AFHBHXEDSA-N 0.000 abstract 1
ZZMNWJVJUKMZJY-UHFFFAOYSA-N Sesamolin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3OC2=CC=C3OCOC3=C2)=C1 ZZMNWJVJUKMZJY-UHFFFAOYSA-N 0.000 abstract 1
VBIRCRCPHNUJAS-UHFFFAOYSA-N Xanthoxylol Chemical compound C1=C(O)C(OC)=CC(C2C3C(C(OC3)C=3C=C4OCOC4=CC=3)CO2)=C1 VBIRCRCPHNUJAS-UHFFFAOYSA-N 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
230000003908 liver function Effects 0.000 abstract 1
125000000325 methylidene group Chemical group [H]C([H])=* 0.000 abstract 1
230000007935 neutral effect Effects 0.000 abstract 1
HGXBRUKMWQGOIE-UHFFFAOYSA-N pinoresinol Chemical compound C1=C(O)C(OC)=CC(C2C3C(C(OC3)C=3C=C(OC)C(O)=CC=3)CO2)=C1 HGXBRUKMWQGOIE-UHFFFAOYSA-N 0.000 abstract 1
VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 abstract 1
KQRXQIPRDKVZPW-ISZNXKAUSA-N sesaminol Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=3OCOC=3C=C2O)=C1 KQRXQIPRDKVZPW-ISZNXKAUSA-N 0.000 abstract 1
KQRXQIPRDKVZPW-UHFFFAOYSA-N sesaminol Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=3OCOC=3C=C2O)=C1 KQRXQIPRDKVZPW-UHFFFAOYSA-N 0.000 abstract 1
OJVGWDJIYBTWDS-UHFFFAOYSA-N sesamolinol Chemical compound C1=C(O)C(OC)=CC(OC2C3C(C(OC3)C=3C=C4OCOC4=CC=3)CO2)=C1 OJVGWDJIYBTWDS-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
- A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
- A23D7/0056—Spread compositions
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/60—Salad dressings; Mayonnaise; Ketchup
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Nutrition Science (AREA)
Epidemiology (AREA)
Mycology (AREA)
Oil, Petroleum & Natural Gas (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Cosmetics (AREA)
Medicines Containing Plant Substances (AREA)
Finger-Pressure Massage (AREA)
Fats And Perfumes (AREA)

AT97112931T 1989-07-21 1990-07-20 Kapsel, enthaltend ein dioxabicyclo(3.3.0)oktan ATE285765T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP1187497A JP3001589B2 (ja)	1989-07-21	1989-07-21	リグナン類含有飲食物
JP8750090		1990-04-03

Publications (1)

Publication Number	Publication Date
ATE285765T1 true ATE285765T1 (de)	2005-01-15

Family

ID=26428763

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
AT97112931T ATE285765T1 (de)	1989-07-21	1990-07-20	Kapsel, enthaltend ein dioxabicyclo(3.3.0)oktan
AT97112930T ATE241978T1 (de)	1989-07-21	1990-07-20	Therapeutische anwendung von dioxabicyclo(3.3.0)oktan-verbindungen
AT90307978T ATE208195T1 (de)	1989-07-21	1990-07-20	Mittel zur verbesserung der leberfunktion

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
AT97112930T ATE241978T1 (de)	1989-07-21	1990-07-20	Therapeutische anwendung von dioxabicyclo(3.3.0)oktan-verbindungen
AT90307978T ATE208195T1 (de)	1989-07-21	1990-07-20	Mittel zur verbesserung der leberfunktion

Country Status (8)

Country	Link
US (1)	US5180588A (de)
EP (3)	EP0826369B1 (de)
AT (3)	ATE285765T1 (de)
CA (2)	CA2021714C (de)
DE (3)	DE69034084T2 (de)
DK (3)	DK0409654T3 (de)
ES (3)	ES2195058T3 (de)
SG (1)	SG42967A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3183664B2 (ja) *	1990-10-22	2001-07-09	サントリー株式会社	コレステロール及び胆汁酸の代謝阻害剤
JP3283274B2 (ja) *	1991-06-15	2002-05-20	サントリー株式会社	新規組成物
US20020031563A1 (en) *	1992-09-30	2002-03-14	Hodge Thomas W.	Method of inhibiting tumor necrosis factor
AU1928295A (en) *	1994-02-25	1995-09-11	New England Deaconess Hospital Corporation	Anti-inflammatory and infection protective effects of sesamin-based lignans
US5397778A (en) *	1994-02-25	1995-03-14	New England Deaconess Hospital Corporation	Enteral formulations for treatment of inflammation and infection
JP3818680B2 (ja) *	1994-05-12	2006-09-06	サントリー株式会社	アレルギー症状の予防又は改善剤
JPH08268887A (ja) *	1995-02-01	1996-10-15	Suntory Ltd	高血圧症又はそれに起因する医学的症状の予防又は改善剤
US5948451A (en) *	1995-07-04	1999-09-07	Suntory Limited	Method of modifying the balance of omega unsaturated fatty acids using a dioxabicyclo octane derivative
FR2738828B1 (fr) *	1995-09-20	1997-10-17	Commissariat Energie Atomique	Utilisation de cyclodextrines naturelles et de leurs derives pour la solubilisation d'agents anti-agregants plaquettaires de la famille des ginkgolides
AU7068896A (en) *	1995-11-09	1997-05-15	Corunum Corporation	Protein composition derived from sesame seed and use thereof
US5811313A (en) *	1997-06-17	1998-09-22	King Pharmaceuticals, Inc.	Identification test for highly refined sesame oil
US20030091553A1 (en) *	2001-10-19	2003-05-15	Gehlsen Kurt R.	Use of histamine to treat liver disease
JP4388248B2 (ja) *	2001-10-29	2009-12-24	株式会社日立製作所	最適ポートフォリオ決定方法および装置
FI114917B (fi) *	2002-08-29	2005-01-31	Hormos Nutraceutical Oy Ltd	Lignaanikomplekseja
CA2592532C (en) *	2004-12-28	2015-02-17	Suntory Limited	Sesamin/episesamin compositions with improved bioavailability
AU2006231967B2 (en)	2005-03-31	2011-09-15	Suntory Holdings Limited	Oil-in-water emulsions containing lignan-class compounds and compositions containing the same
MY147736A (en)	2005-09-30	2013-01-15	Suntory Holdings Ltd	A process and an apparatus for producing episesamin-rich compositions
JP5069416B2 (ja) *	2006-03-15	2012-11-07	サントリーホールディングス株式会社	吸湿性の改善された飲食品用組成物
US20090054443A1 (en)	2006-03-15	2009-02-26	Suntory Limited	Compositions containing riboflavin and sesamin-class compounds
SG172594A1 (en)	2006-03-31	2011-07-28	Suntory Holdings Ltd Jp	Compositions containing lignan-class compounds
CA2680751C (en) *	2007-03-15	2016-01-26	Suntory Holdings Limited	Use of dioxabicyclo[3.3.0]octane derivatives as anti-fatigue agents
KR101528380B1 (ko) *	2007-09-19	2015-06-11	산토리 홀딩스 가부시키가이샤	세사민류와 아라키돈산류를 함유하는 조성물
AU2008301699B2 (en) *	2007-09-19	2014-10-02	Suntory Holdings Limited	Composition Comprising Sesamin Component and Vitamin B1 Component
JP6156795B2 (ja) *	2013-07-05	2017-07-05	公立大学法人大阪市立大学	脂肪細胞分化の抑制用、脂肪細胞の脂肪蓄積量低減用および／または脂肪細胞のアディポネクチン分泌促進用組成物
CN104804012B (zh) *	2015-04-24	2017-06-30	沈阳药科大学	一种具有抗耐药菌活性的化合物止泻木脂素a及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4427694A (en) *	1982-06-11	1984-01-24	The Vinoxen Company, Inc.	Sesamin as a psychotropic agent
EP0269754B1 (de) *	1986-06-13	1993-11-03	TSUMURA & CO.	Biphenylabkömmlinge, verfahren zur herstellung und verwendung
JPH01135892A (ja) *	1987-11-20	1989-05-29	Kuki Sangyo Kk	抗酸化性物質の製造方法
US4868207A (en) *	1988-07-28	1989-09-19	Taisho Pharmaceutical Co., Ltd.	Bis (methylenedioxy) biphenyl compounds useful for the treatment of liver diseases
JP3070611B2 (ja) *	1989-03-07	2000-07-31	サントリー株式会社	△▲上５▼―不飽和化酵素阻害剤
JPH02255616A (ja) *	1989-03-27	1990-10-16	Rooman Kogyo:Kk	肝臓疾患用剤

1990
- 1990-07-20 EP EP97112930A patent/EP0826369B1/de not_active Expired - Lifetime
- 1990-07-20 DE DE69034084T patent/DE69034084T2/de not_active Expired - Lifetime
- 1990-07-20 DK DK90307978T patent/DK0409654T3/da active
- 1990-07-20 AT AT97112931T patent/ATE285765T1/de not_active IP Right Cessation
- 1990-07-20 DK DK97112930T patent/DK0826369T3/da active
- 1990-07-20 CA CA002021714A patent/CA2021714C/en not_active Expired - Lifetime
- 1990-07-20 EP EP90307978A patent/EP0409654B1/de not_active Expired - Lifetime
- 1990-07-20 DK DK97112931T patent/DK0818196T3/da active
- 1990-07-20 EP EP97112931A patent/EP0818196B1/de not_active Expired - Lifetime
- 1990-07-20 SG SG1996001570A patent/SG42967A1/en unknown
- 1990-07-20 AT AT97112930T patent/ATE241978T1/de not_active IP Right Cessation
- 1990-07-20 ES ES97112930T patent/ES2195058T3/es not_active Expired - Lifetime
- 1990-07-20 DE DE69034181T patent/DE69034181T2/de not_active Expired - Lifetime
- 1990-07-20 US US07/555,586 patent/US5180588A/en not_active Expired - Lifetime
- 1990-07-20 CA CA002172855A patent/CA2172855C/en not_active Expired - Lifetime
- 1990-07-20 ES ES90307978T patent/ES2161680T3/es not_active Expired - Lifetime
- 1990-07-20 DE DE69033848T patent/DE69033848T2/de not_active Expired - Lifetime
- 1990-07-20 ES ES97112931T patent/ES2235205T3/es not_active Expired - Lifetime
- 1990-07-20 AT AT90307978T patent/ATE208195T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE69033848D1 (de)	2001-12-13
EP0409654A3 (en)	1992-05-27
EP0409654B1 (de)	2001-11-07
DE69034084D1 (de)	2003-07-10
EP0409654A2 (de)	1991-01-23
DK0409654T3 (da)	2001-12-27
DE69033848T2 (de)	2002-04-04
ES2195058T3 (es)	2003-12-01
EP0826369A1 (de)	1998-03-04
DE69034084T2 (de)	2003-12-04
EP0826369B1 (de)	2003-06-04
DK0826369T3 (da)	2003-09-29
DE69034181T2 (de)	2006-01-26
US5180588A (en)	1993-01-19
CA2172855A1 (en)	1991-01-22
EP0818196A1 (de)	1998-01-14
CA2021714A1 (en)	1991-01-22
EP0818196B1 (de)	2004-12-29
DK0818196T3 (da)	2005-05-02
CA2172855C (en)	2000-02-15
ES2161680T3 (es)	2001-12-16
ATE241978T1 (de)	2003-06-15
ES2235205T3 (es)	2005-07-01
CA2021714C (en)	1996-07-23
ATE208195T1 (de)	2001-11-15
DE69034181D1 (de)	2005-02-03
SG42967A1 (en)	1997-10-17

Legal Events

Date

Code

Title

Description

2005-09-15

UEP

Publication of translation of european patent specification

Ref document number: 0818196

Country of ref document: EP

2010-10-15

EELA

Cancelled due to lapse of time

Publication	Publication Date	Title
DE69034181D1 (de)	2005-02-03	Kapsel, enthaltend ein Dioxabicyclo(3.3.0)oktan
ES2072387T3 (es)	1995-07-16	Medicamento para el tratamiento de trombo, inflamacion y presion sanguinea alta.
IL77452A0 (en)	1986-08-31	Derivatives of arylcyclobutylalkylamines,their preparation and pharmaceutical compositions containing them
DK0519673T3 (da)	2000-08-07	Præparat indeholdende dioxabicyclo{3,3,0}octanderivat
EP0340754A3 (de)	1991-05-15	Monopersulfate von Amino-(poly)percarbonsäuren
WO1999030722A8 (en)	1999-09-10	Pharmaceutical compositions for mucolysis and treatment of inflammation
ZA858418B (en)	1986-07-30	5-alkyl-1-phenyl-2-piperazinoalkylpyrazoline-3-one compounds and methods for the preparation thereof,intermediates for use in the preparation of said compounds and medicaments containing said compounds
EP0374838A3 (de)	1990-09-19	Elektrophotographische Elemente, die bestimmte Anthrachinonderivate als Elektronenübertragungsmittel enthalten
SE8600046L (sv)	1987-07-08	Anvendning av en esterforening som temporer baktericid och produkt innehallande esterforeningen
ATE21695T1 (de)	1986-09-15	Aminocyclopentanester, ihre herstellung und pharmazeutische formulierungen.
IL78273A0 (en)	1986-07-31	(4.2.0)bicyclooctane derivatives,their preparation and pharmaceutical compositions containing them
EP0204148A3 (de)	1987-01-07	[1,4]Benzodioxin- und [1,4]Benzoxazinderivate
JPS527953A (en)	1977-01-21	Preparation of novel methano-anthracene derivatives
ES2007666A6 (es)	1989-07-01	Procedimiento para preparar derivados de isoquinolina y composiciones farmaceuticas correspondientes.
AU2891195A (en)	1996-01-25	Novel 4-substituted 2,6-di-tert-butylphenol compounds, pharmaceutical compositions containing same and preparation method therefor
JPS56103178A (en)	1981-08-18	Pyrimidinoaminomethylenemalonic cyclic ester and its preparation
IE900218L (en)	1990-07-20	Benzopyran derivatives
JPS5328177A (en)	1978-03-16	Optical active piperidine derivatives and their preparation
JPS56122372A (en)	1981-09-25	Prostaglandin i2 derivative
EP0304842A3 (de)	1991-01-16	Isoprenderivate und diese enthaltende Anti-Ulcus-Mittel
JPS55104266A (en)	1980-08-09	Novel pyridone derivative
IL90172A0 (en)	1989-12-15	2,3-dihydro-imidazo(1,2-a)furo and-thieno pyridine derivatives,their preparation and pharmaceutical compositions containing them
JPS53102985A (en)	1978-09-07	Cyclodextrin derivative and its produdtion
JPS53124241A (en)	1978-10-30	Methylenomycin a derivatives and their preparation
EP1067122A3 (de)	2001-02-07	Phenylpyrimidinderivate, Verfahren zur Herstellung, die als wirksamen Stoff enthaltende Flüssigkristallzusammensetzungen, und sie verwendende Flüssigkristallelemente